Cura Therapeutics is a startup based in the United States, 2 tracked investors.
Cura Therapeutics is a company headquartered in the United States. Brouky records 2 investors associated with the company.
Cura Therapeutics develops multimodal immunotherapies, including their lead candidate CT101, to treat metastatic cancers and age-associated diseases by activating immune responses, reducing tumor immunosuppression, and disrupting tumor blood supply.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.